# FARXIGA
> **NDA202293** · New Drug Application · Sponsor: ASTRAZENECA AB · Approved 2014-01-08
## Drug
- **FDA Application Number:** NDA202293
- **Application type:** New Drug Application
- **Brand name:** FARXIGA
- **Generic name:** DAPAGLIFLOZIN
- **Active ingredients:** DAPAGLIFLOZIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ASTRAZENECA AB
- **Manufacturer:** AstraZeneca Pharmaceuticals LP
- **First approval:** 2014-01-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202293)
---
*AI Analytics · CC0 1.0*